ST) Flexitron brachytherapy
afterloading platform for sale and marketing in China, the company said on Thursday.
has been available commercially since the 1970's, and while one market segment, the Low-Dose Rate (LDR) brachytherapy
seeds market, is under pressure in a few regions, globally a revitalization of the brachytherapy
industry is observed for the short term.
Of the 7,359 patients identified, the researchers found that 63 percent of these women received brachytherapy
in combination with EBRT, and 37 percent received EBRT alone.
Researchers will tell the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) that image-guided brachytherapy
is able to deliver very high doses of radiotherapy, which prevent the tumour from growing in over 90 percent of patients, with few serious side-effects to the surrounding normal organs.
may be used either as monotherapy for patients with low-risk or low/intermediate-risk disease, or combined with modest doses of external beam, as a method of dose escalation for patients with higher risk disease.
Research has yet to determine conclusively whether brachytherapy
, EBRT, or surgery is superior at curing cancer confined to the prostate.
Health Minister Dr Brian Gibbons is expected to make an announcement about brachytherapy
at Velindre Hospital, in Cardiff, next month.
On Tuesday, Labour's Assembly Government confirmed brachytherapy
would be available to patients in Wales within weeks.
NASI hopes to use Nomos' international presence, with sales centers in Europe, China and Australia, to springboard its brachytherapy
New data from the Stents and Radiation Therapy (START) trial effectively answer critics who argued that brachytherapy
would merely delay rather than prevent problems in the target vessel, said Dr.
Because the RDX is a platform technology that is scalable in diameter, we can potentially treat both large and small vessels and may have the ability to treat a broader range of patients than some of the other vascular brachytherapy
devices and other restenosis technologies.
Oncura, a unit of GE Healthcare and a leading provider of cancer treatment products, announced a non-exclusive North American distribution agreement with Theragenics Corporation to market Oncura's complete line of Iodine-125 brachytherapy